國家衛生研究院 NHRI:Item 3990099045/2706
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12189/12972 (94%)
造訪人次 : 956434      線上人數 : 859
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/2706


    題名: Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population
    作者: Huang, SP;Chou, YH;Chang, WSW;Wu, MT;Chen, YY;Yu, CC;Wu, TT;Lee, YH;Huang, JK;Wu, WJ;Huang, CH
    貢獻者: National Institute of Cancer Research
    摘要: Recent molecular epidemiological studies have shown that the inherited polymorphisms of VDR gene may be linked to prostate cancer risk and its aggressive phenotypes. However, the findings remain inconclusive. In this study, we investigated the association of the BsmI, ApaI and TaqI polymorphisms of VDR gene with prostate cancer risk in a Taiwanese population. In total, 160 prostate cancer patients and 205 age-matched male controls were studied between December 2000 and February 2003. No significant associations were found between the ApaI and TaqI polymorphisms and the risk of prostate cancer. However, the control group was found to have a significantly higher frequency of the BsmI `BB' and `Bb' genotypes (15.6%) than prostate cancer patients (8.1%). After adjustment for age, patients with Bsm I `BB' or `Bb' genotypes were associated with a twofold decreased risk (OR = 0.50; 95%CI = 0.25-0.98; P = 0.045) for developing prostate cancer than those with `bb' genotypes. This effect was particularly significant among men below the median age of 72 years (P = 0.017). Moreover, stronger associations were found in the advanced stages (T3/T4/N1/M1) and poorly differentiated disease (Gleason score greater than or equal to 7) (`BB' and `Bb' vs `bb': OR = 0.25; 95%CI = 0.07-0.83; P = 0.024 and OR = 0.25; 95%CI = 0.07-0.85; P = 0.026, respectively). Our findings suggest that the VDR BsmI polymorphism may play a significant role in the development of prostate cancer. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
    關鍵詞: Oncology
    日期: 2004-04-15
    關聯: Cancer Letters. 2004 Apr;207(1):69-77.
    Link to: http://dx.doi.org/10.1016/j.canlet.2003.12.006
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0304-3835&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000220931600008
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=12144289486
    顯示於類別:[張文祥] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    000220931600008.pdf145KbAdobe PDF801檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋